| Stem definition | Drug id | CAS RN |
|---|---|---|
| 1834 | 103-16-2 |
None
None
| Date | Agency | Company | Orphan |
|---|---|---|---|
| Nov. 10, 1952 | FDA |
None
None
None
None
| Source | Code | Description |
|---|---|---|
| ATC | D11AX13 | DERMATOLOGICALS OTHER DERMATOLOGICAL PREPARATIONS OTHER DERMATOLOGICAL PREPARATIONS Other dermatologicals |
| FDA MoA | N0000175850 | Melanin Synthesis Inhibitors |
| FDA PE | N0000175851 | Depigmenting Activity |
| FDA EPC | N0000175853 | Depigmenting Agent |
| CHEBI has role | CHEBI:50177 | dermatologic agent |
| CHEBI has role | CHEBI:50904 | alergeno |
| CHEBI has role | CHEBI:64933 | melanin synthesis inhibitors |
None
None
None
| Dissociation level | Dissociation constant | Type (acidic/basic) |
|---|---|---|
| pKa1 | 10.05 | acidic |
None
None
| Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
|---|---|---|---|---|---|---|---|---|---|
| Tyrosinase | Enzyme | INHIBITOR | CHEMBL | CHEMBL | |||||
| Prostaglandin G/H synthase 2 | Enzyme | IC50 | 5.43 | DRUG MATRIX | |||||
| Prostaglandin G/H synthase 1 | Enzyme | IC50 | 5.99 | DRUG MATRIX | |||||
| Sodium-dependent noradrenaline transporter | Transporter | Ki | 5.41 | DRUG MATRIX | |||||
| Arachidonate 15-lipoxygenase | Enzyme | IC50 | 5.31 | DRUG MATRIX |
| ID | Source |
|---|---|
| 4018885 | VUID |
| N0000171571 | NUI |
| D05072 | KEGG_DRUG |
| 4018885 | VANDF |
| C0050962 | UMLSCUI |
| CHEBI:34380 | CHEBI |
| CHEMBL1388 | ChEMBL_ID |
| DB00600 | DRUGBANK_ID |
| 7638 | PUBCHEM_CID |
| 588 | INN_ID |
| C006429 | MESH_SUPPLEMENTAL_RECORD_UI |
| 6830 | IUPHAR_LIGAND_ID |
| 9L2KA76MG5 | UNII |
| 17145 | RXNORM |
| 133 | MMSL |
| 5133 | MMSL |
| 72832 | MMSL |
| 002020 | NDDF |
| 256167003 | SNOMEDCT_US |
| 414760009 | SNOMEDCT_US |
None